208 related articles for article (PubMed ID: 2158451)
1. Ethanol withdrawal seizures and the NMDA receptor complex.
Grant KA; Valverius P; Hudspith M; Tabakoff B
Eur J Pharmacol; 1990 Feb; 176(3):289-96. PubMed ID: 2158451
[TBL] [Abstract][Full Text] [Related]
2. MK-801 potently inhibits alcohol withdrawal seizures in rats.
Morrisett RA; Rezvani AH; Overstreet D; Janowsky DS; Wilson WA; Swartzwelder HS
Eur J Pharmacol; 1990 Jan; 176(1):103-5. PubMed ID: 2155795
[TBL] [Abstract][Full Text] [Related]
3. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal.
Gulya K; Grant KA; Valverius P; Hoffman PL; Tabakoff B
Brain Res; 1991 Apr; 547(1):129-34. PubMed ID: 1830510
[TBL] [Abstract][Full Text] [Related]
4. Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-D-aspartate glutamate receptors to produce persisting spatial learning deficits.
Self RL; Smith KJ; Butler TR; Pauly JR; Prendergast MA
Neuroscience; 2009 Oct; 163(3):868-76. PubMed ID: 19619615
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures.
Valverius P; Crabbe JC; Hoffman PL; Tabakoff B
Eur J Pharmacol; 1990 Aug; 184(1):185-9. PubMed ID: 2145177
[TBL] [Abstract][Full Text] [Related]
6. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures.
Liljequist S
Eur J Pharmacol; 1991 Jan; 192(1):197-8. PubMed ID: 1674917
[No Abstract] [Full Text] [Related]
7. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
Stasheff SF; Anderson WW; Clark S; Wilson WA
Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
[TBL] [Abstract][Full Text] [Related]
8. Allosteric regulation of the N-methyl-D-aspartate receptor-linked ion channel complex and effects of ethanol in ethanol-withdrawal seizure-prone and -resistant mice.
Carter LA; Belknap JK; Crabbe JC; Janowsky A
J Neurochem; 1995 Jan; 64(1):213-9. PubMed ID: 7528263
[TBL] [Abstract][Full Text] [Related]
9. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
Young NA; Lewis SJ; Vajda FJ; Beart PM
Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
[TBL] [Abstract][Full Text] [Related]
10. Mode of blockade by MK-801 of N-methyl-D-aspartate-induced increase in intracellular Ca2+ in cultured mouse hippocampal neurons.
Yuzaki M; Miyawaki A; Akita K; Kudo Y; Ogura A; Ino H; Mikoshiba K
Brain Res; 1990 May; 517(1-2):51-6. PubMed ID: 2165437
[TBL] [Abstract][Full Text] [Related]
11. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats.
Trommer BL; Pasternak JF
Brain Res Dev Brain Res; 1990 May; 53(2):248-52. PubMed ID: 2162746
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures.
Grant KA; Snell LD; Rogawski MA; Thurkauf A; Tabakoff B
J Pharmacol Exp Ther; 1992 Mar; 260(3):1017-22. PubMed ID: 1545374
[TBL] [Abstract][Full Text] [Related]
13. Hypersusceptibility to DMCM-induced seizures during diazepam withdrawal in mice: evidence for upregulation of NMDA receptors.
Tsuda M; Shimizu N; Yajima Y; Suzuki T; Misawa M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):309-15. PubMed ID: 9550303
[TBL] [Abstract][Full Text] [Related]
14. The contribution of voltage-gated and NMDA receptor-gated calcium channels to ethanol withdrawal seizures.
Hoffman PL; Tabakoff B
Alcohol Alcohol Suppl; 1991; 1():171-5. PubMed ID: 1669005
[No Abstract] [Full Text] [Related]
15. The involvement of NMDA receptors in acute and chronic effects of ethanol.
Danysz W; Dyr W; Jankowska E; Glazewski S; Kostowski W
Alcohol Clin Exp Res; 1992 Jun; 16(3):499-504. PubMed ID: 1385679
[TBL] [Abstract][Full Text] [Related]
16. Lorazepam and MK-801 effects on behavioral and electrographic indices of alcohol withdrawal sensitization.
Veatch LM; Becker HC
Brain Res; 2005 Dec; 1065(1-2):92-106. PubMed ID: 16313888
[TBL] [Abstract][Full Text] [Related]
17. Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats.
Kulkarni SK; Ticku MK
Life Sci; 1989; 44(18):1317-23. PubMed ID: 2541293
[TBL] [Abstract][Full Text] [Related]
18. Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion.
Snell LD; Nunley KR; Lickteig RL; Browning MD; Tabakoff B; Hoffman PL
Brain Res Mol Brain Res; 1996 Aug; 40(1):71-8. PubMed ID: 8840015
[TBL] [Abstract][Full Text] [Related]
19. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
Gilbert ME
Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures.
Kapur J; Lothman EW
Epilepsy Res; 1990 Mar; 5(2):103-11. PubMed ID: 2158437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
